Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP-dependent RNA helicase A (RHA) is an enzyme encoded by the DHX9 gene in humans. It functions as a multifunctional ATP-dependent nucleic acid helicase that unwinds DNA and RNA in a 3' to 5' direction. It is capable of unwinding both RNA-RNA and RNA-DNA duplexes. This DEAD/DEAH box protein is implicated in numerous cellular processes involving alteration of RNA secondary structure, including translation initiation, splicing, and ribosome assembly. It may participate in melting of DNA:RNA hybrids that occur during transcription and may play a role in X-linked gene expression. The protein contains two copies of a double-stranded RNA-binding domain, a DEXH core domain, and an RGG box, with the RNA-binding domains and RGG box influencing and regulating RNA helicase activity. The DHX9 gene is located on the long arm (q) of chromosome 1. ATP-dependent RNA helicase A has been shown to interact with multiple proteins including AKAP8L, BRCA1, DDX17 (p72), DDX5 (p68), KHDRBS1, MIZF, NXF1, PRMT1, RELA, and SMN1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-dependent RNA helicase A (RHA).